<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0186-2391</journal-id>
<journal-title><![CDATA[Acta pediátrica de México]]></journal-title>
<abbrev-journal-title><![CDATA[Acta pediatr. Méx]]></abbrev-journal-title>
<issn>0186-2391</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0186-23912015000500369</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedades raras]]></article-title>
<article-title xml:lang="en"><![CDATA[Rare diseases]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carbajal Rodríguez]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Navarrete Martínez]]></surname>
<given-names><![CDATA[Juana Inés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Nacional de Pediatría Clínica de Enfermedades por Deposito Lisosomal ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,PEMEX H.C.S.A.E. Servicio de Genética]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>36</volume>
<numero>5</numero>
<fpage>369</fpage>
<lpage>373</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0186-23912015000500369&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0186-23912015000500369&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0186-23912015000500369&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>International Conference on Rare Diseases and Orphan Drugs (ICORD)</collab>
<source><![CDATA[The Yukiwariso Declaration]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalence of rare diseases: Bibliographic data. Listed in order of decreasingprevalence or number of published case]]></article-title>
<source><![CDATA[Orphanet Report Series]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Unidos para combatir las enfermedades raras]]></article-title>
<collab>OMS</collab>
<source><![CDATA[Boletín de la Organización Mundial de la Salud]]></source>
<year>2012</year>
<volume>90</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>471-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<source><![CDATA[Useful Information on Rare Diseases from an EU Perspective]]></source>
<year></year>
<publisher-name><![CDATA[European Commission]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<collab>Comisión Europea</collab>
<source><![CDATA[Las enfermedades raras: un desafío para Europa]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<source><![CDATA[Public Law 97-414: Orphan Drug Act (1983), designation of drugs for' rare diseases or conditions]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<source><![CDATA[Rare Diseases: Understanding This Public Health Priority]]></source>
<year>2005</year>
<publisher-name><![CDATA[European Organization for Rare Diseases (EURORDIS)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<source><![CDATA[February 29 is Rare Disease Day in Europe]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<source><![CDATA[Rare Disease]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalence of zebras in general practice data from the Continuous Morbidity Registration Nijmegen]]></article-title>
<collab>van de Laar FA.Bor H.van de Lisdonk EH</collab>
<source><![CDATA[Eur J Gen Pract.]]></source>
<year>2008</year>
<volume>14</volume>
<numero>s1</numero>
<issue>s1</issue>
<page-range>44-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<source><![CDATA[What is a Genetic Disease]]></source>
<year></year>
<publisher-name><![CDATA[Genetic AlIiance]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<source><![CDATA[The National Organization for Rare Disorders (NORD)]]></source>
<year>2008</year>
<publisher-name><![CDATA[Reuters]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="">
<source><![CDATA[Canadian Organization for Rare Disorders]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="">
<collab>Federación Española de Enfermedades Raras (FEDER)</collab>
<source><![CDATA[Quienes somos]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="">
<collab>Fundación Geiser</collab>
<source><![CDATA[Misión, Visión, objetivos]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="">
<collab>Federación Colombiana de Enfermedades Raras (FECOER)</collab>
<source><![CDATA[Nuestra Historia]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="">
<source><![CDATA[Decision No 1295/1999/EC of the European Parliament and of the Council of 29 April 1999 adopting a programme of Community action on rare diseases within the framework for action in the field of public health (1999 to 2003)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<source><![CDATA[Consulta Pública las Enfermedades Raras: Un Desafío para Europa]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Luxemburgo ]]></publisher-loc>
<publisher-name><![CDATA[Comisión Europea Dirección General de Sanidad y Protección de los Consumidores Comisión Europea]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rmialle-gómara]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Perucha]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quiñones]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lezaun]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Posada de la Paz]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortalidad por la enfermedad de Huntington en España en el período 1981- 2004]]></article-title>
<collab>Grupo REplER</collab>
<source><![CDATA[Rev Neurol]]></source>
<year>2007</year>
<volume>45</volume>
<page-range>88-90</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Botella Rocamora]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zurriaga Lloréns]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Posada de la Paz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Beneito]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Belprieto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<collab>REpIER</collab>
<source><![CDATA[Atlas Nacional/Provincial de Enfermedades Raras 1999-2003]]></source>
<year>2006</year>
<publisher-name><![CDATA[REpIER editores]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zurriaga Lloréns]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez García]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arizo Luque]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Pérez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos Aceitero]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[García Blasco]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los Registros de Enfermedades en la Investigación Epidemiológica de las Enfermedades Raras en España]]></article-title>
<collab>Red REpIER</collab>
<source><![CDATA[Rev Esp Salud Pública]]></source>
<year>2005</year>
<volume>80</volume>
<page-range>249-57</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estimating the burden of disease for autism spectrum disorders in Spain in 2003]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-Valle]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Posada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Villaverde-Hueso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Touriño]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrari-Arroyo]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Boada]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Autism Dev Disord]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The genetic conception of health is it as radical as claimed?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Health]]></source>
<year>2006</year>
<volume>10</volume>
<page-range>481-500</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[International Statistical Classification of Diseases and Related Health Problems]]></source>
<year>2006</year>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prévalence des maladies rares: Une enquéte bibliographique]]></article-title>
<collab>Orphanet</collab>
<source><![CDATA[Les Cahiers d'orphanet]]></source>
<year>2007</year>
<page-range>1-42</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="">
<source><![CDATA[Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="">
<collab>European Medicines Agency (EMEA)</collab>
<source><![CDATA[Points to consider on the calculations and reporting of prevalence of a condition for orphan designation]]></source>
<year>2002</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="">
<collab>Commission of the European Communities</collab>
<source><![CDATA[Commission Staff Working Document on the experience acquired as a result of the application of Regulation (EC) No 141/2000 on orphan medicinal products and account of the public health benefits obtained Document on the basis 01 Article 10 of Regulation (EC). Brusells 2006]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="">
<collab>Rare Diseases Task Force</collab>
<source><![CDATA[Centres of Reference for rare diseases in Europe: State-of-the-art in 2006 and recommendations of the Rare Diseases Task Force]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="">
<collab>Ministerio de la Salud y de la Protección Social</collab>
<source><![CDATA[Plan Nacional Francés para las Enfermedades Raras 2005-2008. Asegurar la equidad para el acceso al diagnóstico, a los tratamientos y a la atención]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="">
<source><![CDATA[Pathologies couvertes par les centres de reférence pour une maladie rare ou un groupe de maladies rares Iabellisés en 2004, 2005 et 2006]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="">
<collab>DG Sanidad y Protección de los Consumidores</collab>
<collab>Comisión Europea</collab>
<source><![CDATA[The Health Programme 2008-2013]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
